Condition: Pulmonary Hypertension Due to Lung Disease (Disorder) · Sponsor: Liquidia Technologies, Inc.
The purpose of this study is to find out if L606 is safe and if it helps people with high blood pressure in the lungs (pulmonary hypertension) caused by interstitial lung disease (PH-ILD, WHO Group 3). One of the main ways the study will check this is by seeing if people can walk further in six minutes (called the "six-minute walk test"). Another important (secondary) goal is to see how long it takes for PH-ILD to get worse while people are taking L606. One way the study will measure this is by looking at the distance people walk at different times in the study on different doses of L606. Throughout the study, doctors will also closely monitor for any side effects people have to make sure L606 is safe. People who decide to join this study will be randomly (like tossing a coin) placed into one of two groups: one group will get L606 and the other group will get a placebo, which will look like L606 but will not contain any active medicine. At the end of the initial blinded portion of the study, study participants may have the opportunity to enroll in an open-label extension portion of the study where all participants will receive L606.
This description comes directly from the study's public registry record.
Liquidia Point of Contact · 1-888-241-6906 · LiquidiaStudies@liquidia.com
Always discuss trial participation with your own doctor first.
| Arizona Pulmonary Specialists, Ltd. | Scottsdale, Arizona, United States | Recruiting |
| Tampa General Hospital | Tampa, Florida, United States | Recruiting |
| Northwestern University | Chicago, Illinois, United States | Recruiting |
| St. Vincent Cardiovascular Research Institute | Indianapolis, Indiana, United States | Recruiting |
| Summit Health | Bend, Oregon, United States | Recruiting |
| Ordensklinikum Linz GmbH | Linz, Austria | Recruiting |
| Universitair Ziekenhuis Gent | Ghent, Belgium | Recruiting |
| Assistance Publique Hopitaux De Paris | Le Kremlin-Bicêtre, France | Recruiting |
| Universitätsklinikum Giessen und Marburg - Standort Giessen | Giessen, Germany | Recruiting |
| University Medical Center Hamburg-Eppendorf | Hamburg, Germany | Recruiting |
| Medizinische Hochschule Hannover | Hanover, Germany | Recruiting |
| Pauls Stradinš Clinical University Hospital | Riga, Latvia | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07285655